Evidence map›Paper›PMID 25460828›Full record

ArticleProstaglandins & other lipid mediators

The role of PGE2 in intestinal inflammation and tumorigenesis.

David C Montrose, Masako Nakanishi, Robert C Murphy, Simona Zarini, Jeremy P McAleer, Anthony T Vella, Daniel W Rosenberg

Abstract read
In one paragraph

Article in Prostaglandins & other lipid mediators. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Pharmacological reduction of neutrophil infiltration reducesbioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Microsomal Prostaglandin E Synthase-1 Controls Colonic Prostaglandin EInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

David C MontroseCenter for Molecular Medicine and Colon Cancer Prevention, University of Connecticut Health Center, Farmington, CT 06030, United States.
Masako NakanishiCenter for Molecular Medicine and Colon Cancer Prevention, University of Connecticut Health Center, Farmington, CT 06030, United States.
Robert C MurphyDepartment of Pharmacology, University of Colorado Denver, Aurora, CO 80045, United States.
Simona ZariniDepartment of Pharmacology, University of Colorado Denver, Aurora, CO 80045, United States.
Jeremy P McAleerDepartment of Immunology, University of Connecticut Health Center, Farmington, CT 06030, United States.
Anthony T VellaDepartment of Immunology, University of Connecticut Health Center, Farmington, CT 06030, United States.
Daniel W RosenbergCenter for Molecular Medicine and Colon Cancer Prevention, University of Connecticut Health Center, Farmington, CT 06030, United States. Electronic address: rosenberg@uchc.edu.
UConn Health · USUniversity of Colorado Denver · US

Funding

Are ACF Surrogate Markers for Chemoprevention?R01CA159976 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ROSENBERG, DANIEL WILLIAM · 2012 to 2016
$1.9M
Altered Arachidonic Acid Balance and Colon CancerR01CA114635 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ROSENBERG, DANIEL WILLIAM · 2006 to 2010
$1.6M
NCI NIH HHS R01 CA114635NCI NIH HHS R01CA114635NCI NIH HHS R01 CA159976
6 · The paper itself

Abstract

Release of the free fatty acid arachidonic acid (AA) by cytoplasmic phospholipase A2 (cPLA2) and its subsequent metabolism by the cyclooxygenase and lipoxygenase enzymes produces a broad panel of eicosanoids including prostaglandins (PGs). This study sought to investigate the roles of these mediators in experimental models of inflammation and inflammation-associated intestinal tumorigenesis. Using the dextran sodium sulfate (DSS) model of experimental colitis, we first investigated how a global reduction in eicosanoid production would impact intestinal injury by utilizing cPLA2 knockout mice. cPLA2 deletion enhanced colonic injury, reflected by increased mucosal ulceration and pro-inflammatory cytokine expression. Increased disease severity was associated with a significant reduction in the levels of several eicosanoid metabolites, including PGE2. We further assessed the precise role of PGE2 synthesis on mucosal injury and repair by utilizing mice with a genetic deletion of microsomal PGE synthase-1 (mPGES-1), the terminal synthase in the formation of inducible PGE2. DSS exposure caused more extensive acute injury as well as impaired recovery in knockout mice compared to wild-type littermates. Increased intestinal damage was associated with both reduced PGE2 levels as well as altered levels of other eicosanoids including PGD2. To determine whether this metabolic redirection impacted inflammation-associated intestinal tumorigenesis, Apc(Min/+) and Apc(Min/+):mPGES-1(-/-) mice were exposed to DSS. DSS administration caused a reduction in the number of intestinal polyps only in Apc(Min/+):mPGES-1(-/-) mice. These results demonstrate the importance of the balance of prostaglandins produced in the intestinal tract for maintaining intestinal homeostasis and impacting tumor development.

Indexed as

AnimalsColitisCytokinesDinoprostoneGroup IV Phospholipases A2Intestinal MucosaIntestinal NeoplasmsIntestinesIntramolecular OxidoreductasesMiceMice, KnockoutNeoplasm ProteinsProstaglandin-E SynthasesCytokinesDinoprostoneGroup IV Phospholipases A2Intramolecular OxidoreductasesNeoplasm ProteinsProstaglandin-E SynthasesPtges protein, mouseColitisCytosolic phosphlipase A(2)IntestineMicrosomal prostaglandin E synthase-1ProstaglandinsTumorigenesis

Identifiers

PMID25460828
PMCPMC4385488
OpenAlexW2080289362

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.